hydroxychloroquine has been researched along with Aura in 7 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The goal of this systematic review is to assess the published literature for seizure risk with chloroquine or hydroxychloroquine therapy in persons with and without epilepsy." | 7.96 | Assessing the risk of seizures with chloroquine or hydroxychloroquine therapy for COVID-19 in persons with epilepsy. ( Houston, T; Pati, S, 2020) |
| "The goal of this systematic review is to assess the published literature for seizure risk with chloroquine or hydroxychloroquine therapy in persons with and without epilepsy." | 3.96 | Assessing the risk of seizures with chloroquine or hydroxychloroquine therapy for COVID-19 in persons with epilepsy. ( Houston, T; Pati, S, 2020) |
| " However, management of acute seizures in patients with COVID-19 as well as management of PWE and COVID-19 needs to consider potential drug-drug interactions between antiseizure drugs and candidate drugs currently assessed as therapeutic options for COVID-19." | 2.72 | Management of COVID-19 in patients with seizures: Mechanisms of action of potential COVID-19 drug treatments and consideration for potential drug-drug interactions with anti-seizure medications. ( Chandra, PP; Jain, S; Potschka, H; Tripathi, M; Vohora, D, 2021) |
| "A 47-year-old woman with history of seizure disorder (semiology of seizure unknown), not well controlled with antiepileptic drugs since last 30 years presented with 1-year history of intermittent throbbing headache." | 1.62 | Moyamoya angiopathy unmasking systemic lupus erythematosus. ( Das, S; Dubey, S; Pandit, A; Ray, BK, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Kadono, Y | 1 |
| Nakamura, Y | 1 |
| Ogawa, Y | 1 |
| Yamamoto, S | 1 |
| Kajikawa, R | 1 |
| Nakajima, Y | 1 |
| Matsumoto, M | 1 |
| Kishima, H | 1 |
| Pati, S | 1 |
| Houston, T | 1 |
| Das, S | 1 |
| Dubey, S | 1 |
| Pandit, A | 1 |
| Ray, BK | 1 |
| Jain, S | 1 |
| Potschka, H | 1 |
| Chandra, PP | 1 |
| Tripathi, M | 1 |
| Vohora, D | 1 |
| Ravindran, V | 1 |
| SULLI, G | 1 |
| VARRONE, F | 1 |
| Ahuja, GK | 1 |
| Schumacher, GA | 1 |
2 reviews available for hydroxychloroquine and Aura
| Article | Year |
|---|---|
Management of COVID-19 in patients with seizures: Mechanisms of action of potential COVID-19 drug treatments and consideration for potential drug-drug interactions with anti-seizure medications.
Topics: Adenosine Monophosphate; Alanine; Amides; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanize | 2021 |
[EXTRAMALARIAL THERAPUETIC APPLICATIONS OF ANTIMALARIAL DRUGS. 1. CLINICAL UTILIZATIONS].
Topics: Amodiaquine; Antimalarials; Chloroquine; Collagen Diseases; Dermatology; Drug Utilization; Epilepsy; | 1963 |
5 other studies available for hydroxychloroquine and Aura
| Article | Year |
|---|---|
A case of COVID-19 infection presenting with a seizure following severe brain edema.
Topics: Adult; Anti-Bacterial Agents; Anticoagulants; Anticonvulsants; Azithromycin; Betacoronavirus; Brain | 2020 |
Assessing the risk of seizures with chloroquine or hydroxychloroquine therapy for COVID-19 in persons with epilepsy.
Topics: Adolescent; Adult; Aged; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Dr | 2020 |
Moyamoya angiopathy unmasking systemic lupus erythematosus.
Topics: Albuminuria; Angiography, Digital Subtraction; Antibodies, Antinuclear; Anticonvulsants; Antirheumat | 2021 |
Lamotrigine-induced lupus: a case report.
Topics: Adolescent; Anticonvulsants; Antirheumatic Agents; Arthralgia; Epilepsy; Female; Humans; Hydroxychlo | 2011 |
Drug-induced systemic lupus erythematosus. Primidone as a possible cause.
Topics: Electroencephalography; Epilepsy; Female; Humans; Hydralazine; Hydroxychloroquine; Lupus Erythematos | 1966 |